David B. Berger - 03 Mar 2023 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & Chief Operating Officer
Signature
/s/ Rachel Malina, Attorney-in-Fact for David B. Berger
Issuer symbol
TNDM
Transactions as of
03 Mar 2023
Net transactions value
-$34,684
Form type
4
Filing time
07 Mar 2023, 17:41:27 UTC
Previous filing
01 Mar 2023
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $188,600 +10,000 +297% $18.86 13,365 03 Mar 2023 Direct
transaction TNDM Common Stock Sale $411,884 -10,000 -75% $41.19 3,365 03 Mar 2023 Direct F1
holding TNDM Common Stock 242 03 Mar 2023 Berger Family Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise $188,600 +10,000 $18.86 0 03 Mar 2023 Common Stock 10,000 $18.86 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $41.16 to $41.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
F2 The securities are held by the Berger Family Trust dated April 16, 2008.
F3 The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan").
F4 The expiration date for these options is 10 years from the date of grant.